HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Young Suk Park Selected Research

Precision Medicine

1/2018Antitumor activity of sorafenib plus CDK4/6 inhibitor in pancreatic patient derived cell with KRAS mutation.
10/2017Clinical Application of Targeted Deep Sequencing in Solid-Cancer Patients and Utility for Biomarker-Selected Clinical Trials.
1/2016Genomic Profiling of Metastatic Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients in the Personalized-Medicine Era.
10/2011Impact of KRAS mutations on clinical outcomes in pancreatic cancer patients treated with first-line gemcitabine-based chemotherapy.
6/2011Impact of MET amplification on gastric cancer: possible roles as a novel prognostic marker and a potential therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Young Suk Park Research Topics

Disease

124Neoplasms (Cancer)
10/2022 - 10/2004
83Stomach Neoplasms (Stomach Cancer)
08/2022 - 12/2005
52Colorectal Neoplasms (Colorectal Cancer)
11/2022 - 01/2004
27Rectal Neoplasms (Rectal Cancer)
06/2022 - 07/2010
22Neoplasm Metastasis (Metastasis)
08/2022 - 10/2003
21Adenocarcinoma
03/2021 - 01/2004
17Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 04/2007
17Disease Progression
12/2021 - 01/2006
15Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2022 - 03/2006
12Colonic Neoplasms (Colon Cancer)
11/2022 - 04/2007
8Obesity
01/2022 - 06/2016
8Anemia
01/2020 - 01/2006
7Diarrhea
01/2018 - 01/2004
6Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2020
6Nausea
05/2017 - 06/2002
5Hemorrhage
03/2021 - 12/2009
5Neutropenia
04/2019 - 11/2004
5Microsatellite Instability
01/2018 - 09/2010
5Ascites
01/2018 - 01/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 06/2003
5Hepatocellular Carcinoma (Hepatoma)
08/2012 - 11/2004
4Morbid Obesity
12/2021 - 12/2017
4Weight Loss (Weight Reduction)
01/2021 - 10/2017
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2019 - 12/2012
4Fatigue
01/2018 - 03/2011
4Carcinoma (Carcinomatosis)
09/2015 - 10/2003
4Vomiting
06/2015 - 06/2002
3Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2021 - 06/2015
3Lymphatic Metastasis
12/2017 - 09/2014
3Carcinogenesis
11/2017 - 08/2009
3Hand-Foot Syndrome
05/2017 - 08/2007
3Abdominal Pain (Pain, Abdominal)
10/2015 - 03/2011
3Thrombocytopenia (Thrombopenia)
10/2014 - 11/2004
3Anorexia
05/2012 - 08/2007
2Aggressive Fibromatosis (Desmoid)
10/2022 - 04/2014

Drug/Important Bio-Agent (IBA)

37Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2022 - 07/2005
33Capecitabine (Xeloda)FDA Link
06/2022 - 01/2004
23Fluorouracil (Carac)FDA LinkGeneric
08/2022 - 04/2005
23Irinotecan (Camptosar)FDA LinkGeneric
03/2022 - 01/2004
20GemcitabineFDA Link
01/2021 - 03/2006
19Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2009
18Leucovorin (Folinic Acid)FDA Link
08/2022 - 04/2005
17Cisplatin (Platino)FDA LinkGeneric
01/2019 - 06/2003
14Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2003
12Bevacizumab (Avastin)FDA Link
03/2022 - 02/2013
10Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 04/2007
9Cetuximab (Erbitux)FDA Link
10/2019 - 04/2011
8Simvastatin (Zocor)FDA LinkGeneric
06/2022 - 09/2009
8Pharmaceutical PreparationsIBA
01/2021 - 01/2016
7XELOXIBA
07/2019 - 04/2011
7EverolimusFDA Link
01/2019 - 07/2011
6Docetaxel (Taxotere)FDA Link
04/2019 - 01/2007
6Monoclonal AntibodiesIBA
01/2019 - 09/2015
6Phosphotransferases (Kinase)IBA
11/2015 - 04/2007
6ParaffinIBA
09/2014 - 01/2004
5Paclitaxel (Taxol)FDA LinkGeneric
08/2022 - 06/2003
5regorafenibIBA
01/2020 - 10/2015
5Sunitinib (Sutent)FDA Link
04/2014 - 01/2010
4Imatinib Mesylate (Gleevec)FDA Link
10/2022 - 01/2009
4Glucose (Dextrose)FDA LinkGeneric
01/2022 - 06/2020
4B7-H1 AntigenIBA
01/2021 - 01/2016
4PlatinumIBA
01/2021 - 11/2010
4Carcinoembryonic AntigenIBA
04/2020 - 12/2017
4DNA (Deoxyribonucleic Acid)IBA
06/2017 - 10/2002
4Hemoglobins (Hemoglobin)IBA
06/2017 - 01/2006
4Sorafenib (BAY 43-9006)FDA Link
01/2017 - 01/2011
4Tyrosine Kinase InhibitorsIBA
01/2016 - 01/2011
3RNA (Ribonucleic Acid)IBA
10/2022 - 01/2020
3Immune Checkpoint InhibitorsIBA
09/2022 - 01/2021
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
03/2020 - 01/2014
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 04/2007
3Biological ProductsIBA
01/2019 - 01/2018
3EnzymesIBA
01/2018 - 01/2013
3Alkaline PhosphataseIBA
01/2018 - 01/2007
3Small Interfering RNA (siRNA)IBA
01/2018 - 12/2011
3Messenger RNA (mRNA)IBA
01/2017 - 01/2004
3SurvivinIBA
09/2016 - 08/2009
3pazopanibFDA Link
06/2016 - 11/2014
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2014 - 08/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009 - 11/2004
2Calcibiotic Root Canal SealerIBA
11/2022 - 10/2015
2Indicators and Reagents (Reagents)IBA
10/2022 - 01/2018
2Coenzyme A (CoA)IBA
06/2022 - 11/2014

Therapy/Procedure

79Drug Therapy (Chemotherapy)
01/2022 - 12/2002
55Therapeutics
11/2022 - 10/2003
39Gastrectomy
01/2022 - 01/2010
23Chemoradiotherapy
06/2022 - 08/2004
17Combination Drug Therapy (Combination Chemotherapy)
04/2015 - 12/2002
16Radiotherapy
04/2022 - 09/2007
11Bariatric Surgery
01/2022 - 10/2017
11Neoadjuvant Therapy
08/2021 - 01/2007
11Adjuvant Chemotherapy
11/2019 - 01/2007
5Gastric Bypass (Roux-en-Y Gastric Bypass)
10/2021 - 10/2017
5Salvage Therapy
01/2020 - 12/2011
5Precision Medicine
01/2018 - 06/2011
4Length of Stay
03/2021 - 10/2018
4Immunotherapy
01/2021 - 09/2017
4Adjuvant Chemoradiotherapy
12/2018 - 12/2005
4Lymph Node Excision (Lymph Node Dissection)
06/2017 - 01/2012
3Metastasectomy
04/2021 - 09/2010